EAT
0.02
900%
XST
0.03
-40%
PIL
0.006
200%
HYD
0.014
-39.1%
TRI
0.031
158.3%
ENT
0.006
-33.3%
AGD
0.115
144.7%
ELS
1.345
-32.8%
CUF
0.04
135.3%
EOS
5.39
-29.9%
HWK
0.035
105.9%
EQS
0.012
-29.4%
AYM
0.006
100%
ERD
1.7
-29.2%
SKN
0.006
100%
T3D
0.085
-29.2%
NVA
1.535
98.1%
DTM
0.005
-28.6%
RML
0.086
91.1%
SPQ
0.01
-28.6%
CNJ
0.013
85.7%
1MC
0.05
-26.5%
RDN
0.009
80%
ATC
0.04
-25.9%
EUR
0.465
78.8%
DTR
0.4
-25.2%
RAU
0.31
72.2%
MTB
0.012
-25%
BIT
0.005
66.7%
RNX
0.006
-25%
RLC
0.005
66.7%
TEG
0.003
-25%
AON
0.013
62.5%
CDR
0.022
-24.1%
AMX
0.3
53.8%
DRO
4.59
-23.9%
BMG
0.023
53.3%
SLM
0.061
-23.8%
CAE
0.064
52.4%
PSL
0.032
-23.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf